Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (dis CoVeRy): a phase 3, randomised, controlled, open-label trial
2021 Jun 23;385(12):10911103
The UK and EU product information contains warnings about thyroid C-cell tumours, which differs from the US where these medications carry a boxed warning and formal contraindications for certain thyroid conditions
Certain individuals should avoid glutathione supplementation, including those with specific health conditions such as asthma or anyone undergoing chemotherapy
Mucosal-associated invariant and T cell subsets respond to initial Mycobacterium tuberculosis infection
Prescribing it to patients without diabetes is off-label, not supported by clinical trial data, and almost never covered by insurance